J 2022

Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review

PEPERA, G., M. S. TRIBALI, Ladislav BAŤALÍK, I. PETROV, J. PAPATHANASIOU et. al.

Basic information

Original name

Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review

Authors

PEPERA, G., M. S. TRIBALI, Ladislav BAŤALÍK (703 Slovakia, guarantor, belonging to the institution), I. PETROV and J. PAPATHANASIOU

Edition

Reviews in Cardiovascular Medicine, SINGAPORE, IMR PRESS, 2022, 1530-6550

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Singapore

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.700

RIV identification code

RIV/00216224:14110/22:00125463

Organization unit

Faculty of Medicine

UT WoS

000755022100017

Keywords in English

Cardiovascular disease; COVID-19; SARS-CoV-2; Coronavirus disease pandemic; Risk factors; Epidemiology; Cardiovascular risk factors; Prognosis; Systematic review

Tags

Tags

International impact, Reviewed
Změněno: 20/7/2022 10:14, Mgr. Tereza Miškechová

Abstract

V originále

Background: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused more than five milion deaths worldwide. Several studies have elucidated the role of risk factors in the prognosis of cardiovascular disease (CVD) in the progression of COVID-19 pandemic. This systematic review assesses the link between COVID-19 and cardiovascular risk factors, and investigates the prognosis in the case of myocardial injury. Methods: A literature search was performed to identify relevant articles in Pubmed, MEDLINE, Elsevier, and Google Scholar the last two years using the terms: COVID-19, CVD, risk factors, cardiovascular risk factors, SARS-CoV-2, lockdown, hypertension, and diabetes mellitus. Exclusion criteria were the studies associated with pediatric and pregnant COVID-19 patients. Results: After screening through 3071 articles, 10 studies were included in this review that captured the findings from 3912 participants. Included studies found that preexisting CVD was linked to worse outcomes and increased risk of death in patients with COVID-19, whereas COVID-19 itself also induced myocardial injury, arrhythmia, acute coronary syndrome, and venous thromboembolism. Conclusions: Cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity were associated with intensive care unit admission and poor prognosis. Cardiovascular risk factors are crucial for the progression of COVID-19, and infected patients should be constantly monitored and follow strict hygiene and decrease their social interactions.